These data suggest that IL-6 and IL-10 might act in chronic inflammation and insulin resistance whereas IL-12 and TNF may be involved in promoting liver damage and NAFLD progression. The gene discussed is IL10; the disease is metabolic dysfunction-associated steatotic liver disease.